Sharenet Sites 
Sharenet Sites
NUT - Nutritional Holdings Limited - Renewal of existing Cautionary Announcement NUTRITIONAL HOLDINGS LIMITED (Previously Imuniti Holdings Limited) (Incorporated in the Republic of South Africa) (Registration Number 2004/002282/06) Share code: NUT ISIN: ZAE000156485 ("Nutritional Holdings" or "the Company") RENEWAL OF EXISTING CAUTIONARY ANNOUNCEMENT 1 Shareholders are referred to the previous cautionary announcement dated 12 January 2012. 2 Further to the aforementioned announcement, shareholders are informed that during the latter part of 2011, an application was made together with Edge to Edge Global Investment Limited ("E2E") to the National Industrial Participation Secretariat ("IPS") of the Department of Trade and Industry ("DTI") for the funding of the Imuniti Nutritional Supplement Combo Pack ("ISCP") Project ("the DTI Application"). This application was made following the positive clinical trial results on the ISCP as announced on SENS on 23 March 2011. 3 The National Industrial Participation Programme`s role is to fast-track investment, exports and technology development in South Africa by utilizing the instrument of government procurement to leverage such initiatives. All government and parastatal sellers/suppliers with an imported content equal to or exceeding a certain amount incur an Industrial Procurement Obligation and are required to participate in the South African economy. It is on this obligation that the application was made for the ISCP Project. 4 Nutritional Holdings manufactures the ISCP for E2E, the owners of the intellectual property related to the ISCP, pursuant to the exclusive manufacturing agreement concluded with E2E as announced on SENS dated 14 June 2011. 5 The DTI Application was made in order to fund the following: 5.1 the upgrade of the manufacturing facilities of Nutritional Holdings in order to meet the increase in demand of the ISCP when the distribution of the ISCP escalates to a point where the facilities are not able to meet the demand; 5.2 the cost of the medical Phase II trials to be carried out by E2E on the ISCP for reaffirmation purposes; and 5.3 the cost of setting up distribution outlets. 6 Written confirmation has been received from the IPS that on 15 January 2012 a decision was made by the Industrial Participation Internal Control Committee approving the concept in principle, which allows negotiations with obligors to commence. 7 In addition to the DTI Application, application was also made to the Industrial Development Corporation ("the IDC Application") last year in conjunction with E2E for the funding of the ISCP project. The IDC has confirmed that they have completed their basic assessment of the application and any further developments in this regard will be communicated to shareholders as and when they arise. 8 Shareholders are therefore advised to continue exercising caution when dealing in the Company`s securities until a further announcement has been made regarding either of the DTI Application or the IDC Application. Umhlanga 7 February 2012 Designated advisor: PSG Capital Proprietary Limited Date: 07/02/2012 17:38:01 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
